share_log

金城医药(300233.SZ):具备复合型的、多技术的生物合成与化学合成双平台

Shandong Jincheng Pharmaceutical Group (300233.SZ): Equipped with a composite, multi-technology biosynthesis and chemical synthesis dual platform.

Gelonghui Finance ·  Nov 21 20:12

Gelonghui, November 21st | Shandong Jincheng Pharmaceutical Group (300233.SZ) stated in recent investor relations activities that the company has a composite, multi-technical dual platform for biological synthesis and chemical synthesis, with about 2,000 chemical synthesis team members and 400 synthetic biologists. The dual-platform advantage solves the problems of low efficiency and high cost in traditional products and traditional industries. The company's product selection is focused on the pharmaceutical + health industry, with certain technological barriers.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment